TAK-660-403 4+

ERT,INC

    • Free

Screenshots

Description

An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)

What’s New

Version 1.2

- Bug fixes for iOS 17

App Privacy

The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Not Collected

The developer does not collect any data from this app.

Privacy practices may vary based on, for example, the features you use or your age. Learn More

More By This Developer

Janssen E.mbrace
Medical
Astellas 2693-CL-0312
Medical
REIMAGINE 2 Study App
Medical
U & Resolution
Medical
MK5684-004
Medical
NOVONOR_NN7415-4307
Medical

You Might Also Like

FitsMind Daily Affirmations
Health & Fitness
myPKFiT
Medical
Biking Distance Tracker
Health & Fitness
Blood Pressure Monitor - iCare
Medical
Happy Bob
Medical
Surf Athlete: Surf Training
Health & Fitness